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Abstract
We performed a genome-wide search for pairs of susceptibility loci that jointly contribute to
rheumatoid arthritis in families recruited by the North American Rheumatoid Arthritis
Consortium. A complete two-dimensional (2D) non-parametric linkage scan was carried out using
380 autosomal microsatellite markers in 511 families. At each 2D peak we obtained the most likely
underlying genetic model explaining the two-locus effects, defining epistasis as a departure from an
additive or a multiplicative two-locus penetrance function. The highest peak in the surface identified
an epistatic interaction between loci 6p21 and 16p12 (two-locus lod score = 18.02, epistasis P <
0.012). Significant and suggestive two-locus effects were also obtained for region 6p21 in
combination with loci 18q21, 8p23, 1q41, and 6p22, while the highest 2D peaks excluding region
6p21 were observed at locus pairs 8p23-18q21 and 1p21-18q21. The 2D peaks were further
examined using combined microsatellite and single-nucleotide polymorphism (SNP) marker
genotypes in 744 families. The two-locus evidence for linkage increased for region pairs 6p21-
18q12, 6p21-16p12, 6p21-8p23, 1q41-6p21, and 6p21-6p22, but decreased for pairs of regions that
did not include locus 6p21. In conclusion, we obtained evidence for multi-locus interactions in
rheumatoid arthritis that are mediated by the major susceptibility locus at 6p21.
Background
Multiple loci are likely to influence susceptibility to rheu-
matoid arthritis (RA). Genome-wide scans for multiple
interacting loci have been performed in model organisms
[1] and more recently for complex human traits [2,3]. The
hypothesis that genetic interactions contribute to RA has
recently been examined using linkage analysis of selected
regions [4]. However, a systematic genome-wide search
for pair-wise interactions in RA has not yet been per-
formed. The aim of this study was to carry out a genome-
wide search for pairs of loci that jointly contribute to RA
under two-locus genetic models that include epistasis. To
achieve this, we performed a two-dimensional (2D) non-
parametric linkage scan in sibling pairs affected with RA
from the families in the North American Rheumatoid
Arthritis Consortium (NARAC) collection. We detected a
genome-wide significant epistatic interaction between
loci 6p21 and 16p12, as well as several other pairs of loci
that contribute to RA jointly and include locus 6p21.
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Methods
The genotyped sample of families provided by NARAC to
the Genetic Analysis Workshop 15 consisted of 757 fami-
lies (8017 individuals), in which at least one individual
per family was genotyped [5,6]. We initially examined evi-
dence for two-locus linkage using 380 autosomal micros-
atellite markers in 511 NARAC families, with 627 affected
full-sib pairs (ASP), 29 affected maternal half-sib pairs
(AMHSP), and 2 affected paternal half-sib pairs (APHSP).
The peaks in the 2D surface were also tested for two-locus
evidence for linkage using all of the available genotype
data in the NARAC collection. There were 744 families
(with 911 ASP, 43 AMHSP, and 2 APHSP) with genotypes
available for either the autosomal microsatellite markers
(380 markers), or for the autosomal single-nucleotide
polymorphism (SNP) markers (5407 markers), or for all
microsatellite and SNP autosomal markers (5787 mark-
ers). Marker order was based on build 18 of the human
genome and genetic distances were obtained from the
Rutgers map [7]. Where genetic distances were unavaila-
ble, we used physical distances to linearly interpolate the
corresponding Rutgers cM location, and in cases where
markers were located beyond the ends of the Rutgers map,
we assumed that 1 cM = 1 Mb. In the lod-score calcula-
tions we used Haldane map units, founder allele frequen-
cies, and if SNP markers were included in the analysis, we
clustered markers using a linkage disequilibrium thresh-
old of r2 > 0.1.
Non-parametric linkage analysis was carried out initially
using the single-locus maximum lod score (MLS) test sta-
tistic [8]. Two-locus non-parametric linkage analysis was
performed using the two-locus extension of the MLS
[9,10] implemented in Merloc [3]. Merloc uses likelihood
estimates from Merlin [11] to estimate the joint two-locus
allele sharing probabilities, which are then used in the cal-
culation of the two-locus MLS using numerical maximiza-
tion. The two-locus MLS under the most general two-locus
model (GEN) is a function of the eight variance compo-
nents at the two loci – the additive and dominance vari-
ances at locus 1 (VA1 and VD1) and 2 (VA2 and VD2), and
the four epistatic variances (VA1A2, VA1D2, VD1A2, and
VD1D2). Different genetic models can be fitted to the data
by restricting the number of free variance components, for
example, two-locus additive (ADD) or multiplicative
(MUL) models and single-locus (SL) models are nested
within the general epistatic model.
In the variance-component framework, epistasis can be
defined as a departure from an additive or a multiplicative
two-locus penetrance function. To assess the evidence for
epistasis as a departure from additivity, the two-locus MLS
under the general model may be compared to the MLS
under the nested additive model with no interaction
terms (GEN-ADD). Alternatively, a test for epistasis would
compare the MLS under the general model with that
under the multiplicative model (GEN-MUL). The MLS
under a two-locus epsilon-epistatic model [3] (where a
single parameter, ε, captures the degree of epistasis) and
the maximum-likelihood estimate of ε can also be used to
indicate the degree of epistasis (with ε = 0 corresponding
to an additive model, ε = 1 to the multiplicative model,
and ε > 103 to an extreme epistatic model).
We used previously published [3] significance thresholds
to assess the significance of our findings of two-locus link-
age compared to a null model in which neither locus
affects the trait, where GEN = 5.85 corresponds to 2D
genome-wide type I error rate of 0.05, and GEN = 4.30
corresponds to suggestive evidence for two-locus linkage.
To assess the significance of the two-locus linkage results
for pairs of loci that included 6p21, we performed two-
locus simulations of chromosome pairs 6–16, 6–18, 6–8,
and 6–1, by keeping chromosome 6 fixed (real data)
against 1000 replicates of the simulated second chromo-
some (null effect). To estimate the point-wise significance
of our findings of epistasis defined either as a departure
from additivity or multiplicativity, we simulated two fully
informative markers under the null two-locus model of
interest (ADD for GEN-ADD and MUL for GEN-MUL).
This was achieved by sampling from the observed two-
locus allele sharing distribution under the null two-locus
model (ADD or MUL) during the linkage analysis of our
actual data. This procedure was performed at each 2D
coordinate of interest and 100,000 replicates were used to
obtain the GEN-ADD or GEN-MUL thresholds at that
coordinate. A similar approach was applied to assess the
significance of a secondary locus at 6p22. We generated
100,000 simulates of fully-informative markers, by sam-
pling from the observed 6p21 single-locus allele sharing
distribution, and subsequently we analyzed the replicates
under the GEN model.
Results
Single-locus (SL) linkage analysis of the microsatellite
genome-scan data in 511 NARAC families (Figure 1A)
indicated a major locus on 6p21 (SL MLS = 15.55), and
several loci with suggestive evidence for linkage (SL MLS >
1.5) at 1p21 (SL MLS = 1.67), 1q42 (SL MLS = 1.70), 5p15
(SL MLS = 1.51), 8p23 (SL MLS = 2.00), 12q15 (SL MLS =
1.51), and 18q21 (SL MLS = 2.3).
We performed a 2D linkage scan by computing the two-
locus general model MLS at each marker-pair grid coordi-
nate in the genome (Figure 1B). For each 2D peak we
examined two-locus genetic models, starting with a gen-
eral model that fits a wide range of epistatic models, and
then restricted the number of free parameters in a stepwise
manner to estimate the model that best fits the interaction
(Table 1). To assess the significance of our findings, weBMC Proceedings 2007, 1(Suppl 1):S63 http://www.biomedcentral.com/1753-6561/1/S1/S63
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initially used previously published simulation thresholds
that assumed a null effect at both loci. The genome-wide
significant and suggestive results using these simulations
comprised all peaks including region 6p21 and two peaks
(1p21-18q21 and 8p23-18q21) that excluded region
6p21.
The highest two-locus general model MLS across the
genome was obtained between two loci on 6p21 and
16p12 (Figure 1C; two-locus MLS = 18.02, P < 0.001) and
the most likely model describing this interaction was a
model of extreme epistasis (GEN-ADD P = 0.011, GEN-
MUL P = 0.011, ε ≥ 103). Because the 2D peaks involving
6p21 always surpassed the genome-wide significance
threshold of 5.85 (which assumes a null effect at either
locus), we also assessed the significance of two-locus
results involving 6p21 using simulations of chromosome
pairs in which the null model included a single-locus
effect at 6p21 alone. The results from these analyses indi-
cated significant (chromosome-wide) effects at regions
16p12 (P = 0.012), 18q21 (P = 0.045), and 8p23 (P =
0.05) and a suggestive effect at 1q42 (P = 0.12), which was
independent of 6p21. The two-locus effects observed at
locus pairs 6p21-18q21, 6p21-8p23, 6p21-1q42, and
Genome-wide linkage analysis of the microsatellite marker data Figure 1
Genome-wide linkage analysis of the microsatellite marker data. A, Single-locus linkage results. B, Two-locus genome 
scan using the general two-locus model MLS. Above the diagonal are genome-wide results on a two-locus MLS scale of 0–6, 
and below the diagonal are chromosome 6 results on a two-locus MLS scale of 15–18. Highest fine-grid two-locus peaks in the 
2D MLS surface, including (C) and excluding (D) chromosome 6.BMC Proceedings 2007, 1(Suppl 1):S63 http://www.biomedcentral.com/1753-6561/1/S1/S63
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6p21-6p22 were best explained by the additive or multi-
plicative two-locus models (see Table 1). When 6p21 was
excluded from the 2D surface, the highest two-locus MLS
occurred between regions 8p23 and 18q21 (two-locus
MLS = 4.6, P  = 0.34) and the most likely underlying
genetic model describing these effects was an additive
two-locus model (Figure 1D). To attempt to refine the
localization of the susceptibility regions, we also esti-
mated 1-lod unit support intervals from the two-locus
results (Table 1).
The peaks in the microsatellite 2D scan were also exam-
ined for two-locus evidence for linkage using all of the
available genotype data in the NARAC collection. The
results (Table 1) indicate that the evidence for linkage at
the 2D peaks involving 6p21 increases, in particular for
locus pair 6p21-18q21, however, the evidence for linkage
involving loci 8p23-18q21 and 1p21-18q21 decreases.
We also examined the evidence for two linked loci on
chromosome 6 in more detail, using sex-averaged and sex-
specific maps (Figure 2). Assuming that a major RA locus
is present at 6p21, the evidence for a secondary RA locus
on chromosome 6 is highest at marker D6S2439 under an
additive two-locus model. The MLS at D6S2439, inde-
pendent of D6S1629, ranges between 0.93 and 1.9,
depending on the inclusion of the SNP data in the analy-
sis and whether sex-averaged or sex-specific distances are
used. The evidence for linkage at D6S2439 is highest in
the microsatellite analyses using the sex-averaged map,
1.9 (P = 0.004), and is lowest in the analyses of the com-
bined data under sex-specific maps, 0.93 (P = 0.048).
Discussion and conclusion
We performed a genome-wide search for pair-wise interac-
tions that contribute to RA susceptibility in the NARAC
family collection. The highest peak on the 2D surface
involved an epistatic interaction between two loci on
6p21 and 16p12. We also detected pairs of loci that jointly
contribute to RA under two-locus additive and multiplica-
tive models, 6p21-18q21, 6p21-8p23, and 6p21-1q41.
Suggestive evidence for a secondary gene on 6p22, inde-
pendent of the major locus on 6p21, was also obtained,
but addition of SNP genotypes and use of more precise
sex-specific maps in the two-locus analyses of chromo-
some 6 reduced the evidence for linkage at 6p22, indicat-
ing that these results should be interpreted with caution.
Our findings are consistent with previous interaction
analyses of genetic interactions in RA [4]. John et al. [4]
examined evidence for epistasis among selected RA sus-
ceptibility regions in the families used in this study and
additional data, defining interaction as a departure from a
multiplicative two-locus model. The two-locus results
obtained at locus pair 6p21-16p12 coincide exactly in the
two studies, however, although we observe a two-locus
peak at region pair 6p21-6q16 (Figure 2), the magnitude
of the peak does not attain significance, which might be
due to differences in genetic maps and slight changes in
the data structure between the two studies.
Multi-locus linkage analysis methods have been devel-
oped and applied to complex human traits. Such methods
are useful in detecting novel loci that contribute to the
trait susceptibility only through their genetic interactions,
and in establishing the type of interaction among suscep-
tibility loci. The approach used in this study can examine
entire genomes for potential pair-wise or higher-order
interactions, however, interpreting the genome-wide sig-
nificance of the findings is challenging, in particular when
there is strong single-locus evidence for linkage. All of the
regions involved in the 2D peaks in our analyses have at
least suggestive single-locus effects. Therefore, the results
Table 1: Highest two-locus peaks on the 2D surface
Two-locus resultsa
Locus 1 Θ Locus 2 GEN 
(microsatellite)
GEN-ADD P-value GEN-MUL P-value εb GENc 
(microsatellite and SNP)
1-Lod unit support intervals 
(cM)d
Entire 2D surface
6p21 0.5 16p12 18.02 0.011 0.011 103 21.86 (51–55); (37–59)
6p21 0.5 18q21 17.90 0.254 0.937 0.66 23.04 (51–55); (52–85)
6p21 0.5 8p23 17.85 0.036 0.413 8.12 22.27 (51–55); (0–26)
1q42 0.5 6p21 17.44 0.642 0.083 0 21.58 (221–270); (51–55)
6p22 0.11 6p21 17.44 0.999 0.009 0 21.5 (31–47); (51–58)
2D surface excluding 6p21 interactions
8p23 0.5 18q21 4.60 0.631 0.587 0 3.24 (0–26); (52–85)
1p21 0.5 18q21 4.33 0.114 0.410 53 3.42 (126–153); (26–85)
aTwo-locus general model MLS obtained in 511 families with microsatellite genotypes alone. Empirical P-values assessing the significance of the difference in two-locus MLS 
under the general and additive models, and the general and multiplicative models. Significant deviations from the null two-locus model (ADD or MUL) are shown in bold. 
Empirical P-values were also obtained assuming a null effect at the two loci using published thresholds [3], and for pairs of loci excluding 6p21 these were estimated at P = 0.34 
for 8p23-18q21, and P = 0.53 for 1p21-18q21.
bMaximum-likelihood estimate of epsilon.
cTwo-locus general model MLS in 744 families using combined microsatellite and SNP data.
d1-Lod unit support intervals (to nearest Rutgers Kosambi cM) obtained using the GEN statistic from the microsatellite data set.BMC Proceedings 2007, 1(Suppl 1):S63 http://www.biomedcentral.com/1753-6561/1/S1/S63
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of this study are more useful for elucidating the nature of
the interactions between previously identified RA suscep-
tibility loci, rather than in identifying novel loci for RA
susceptibility. The two-locus findings are also useful in
potentially refining the susceptibility regions, by yielding
narrower 1-lod unit support intervals.
Our primary results were based on analyses of the micro-
satellite genotype data alone, while SNP genotypes were
added to confirm the effects observed at the two-locus
peaks. The inclusion of SNP genotypes in the 2D scan of
the peaks allowed for more informative analyses, with
more confidence in the two-locus effects observed at the
2D peaks. A follow-up to this study would involve a com-
plete 2D genome-wide analysis of the combined SNP and
microsatellite data in the NARAC families. These analyses
prove computationally prohibitive at present.
The analyses of the NARAC data indicated that if genetic
interactions contribute to RA, they are most likely medi-
ated by the major locus at 6p21. This study was aimed at
searching for pair-wise interactions in RA, but higher
dimension interactions may also exist and should be
examined in future analyses.
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Two-locus fine-scale linkage analysis of chromosome 6 Figure 2
Two-locus fine-scale linkage analysis of chromosome 6. Single-locus (SL MLS) and two-locus (GEN) analyses of chro-
mosome 6 were performed assuming a disease locus at D6S1629 (HLA denotes the single-locus MLS score at D6S1629). 
Results for the microsatellite markers using sex-averaged (A) and sex-specific (B) genetic maps, and the combined microsatel-
lite and SNP markers using sex-averaged (C) and sex-specific (D) genetic maps.Publish with BioMed Central    and   every 
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